About Anita Lyn Sabichi
- Accolades
-
-
Board Certified in Medical Oncology
-
Pleural and Lung Cancer
-
20+ Years of Experience
-
Sabichi is involved in experimental therapeutics of lung, head and neck cancers. She helped investigate a clinical trial involving bevacizumab in the treatment of head and neck cancers. Bevacizumab, also known by brand name Avastin, was recently added to the National Comprehensive Cancer Network’s first-line mesothelioma treatment recommendations.
Sabichi, who has been in practice for more than 20 years, graduated from the University of Colorado School of Medicine. She completed her residency at New York Presbyterian Hospital and her fellowship at the National Institutes of Health Clinical Center.
See More Top Mesothelioma DoctorsDisclaimer: Dr. Anita Lyn Sabichi has no professional affiliation with Asbestos.com.

Get a Free Treatment Guide Sent Overnight
Get Yours NowFind Ways to Pay for Treatment Costs
Get StartedFind an Active Mesothelioma Clinical Trial
Find NowGet a Free Treatment Guide Sent Overnight
Find Ways to Pay for Treatment Costs
Find an Active Mesothelioma Clinical Trial
1 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
- Baylor College of Medicine. (n.d.). Anita Lyn Sabichi, M.D. Retrieved from: https://www.bcm.edu/people/view/anita-sabichi-m-d/b24cba2b-ffed-11e2-be68-080027880ca6
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Thank you for your feedback. Would you like to speak with a Patient Advocate?
Related Topics
Share this article
Last Modified July 24, 2020